Biblio

Export 3139 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
A. Abraham Daniel, Silzer, T., Sun, J., Zhou, Z., Hall, C., Phillips, N., and Barber, R., “Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1229-1239, 2023.
V. E Daniel, Kleiman, M. J., and Galvin, J. E., “Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.”, J Alzheimers Dis, vol. 91, no. 1, pp. 495-506, 2023.
S. Dardenne, Delrieu, J., Sourdet, S., Cantet, C., Andrieu, S., Mathiex-Fortunet, H., Fougère, B., and Vellas, B., “Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1567-1578, 2017.
G. Darnai, Nagy, S. Anett, Horváth, R., Ács, P., Perlaki, G., Orsi, G., Kovács, N., Altbäcker, A., Plózer, E., Tényi, D., Weintraut, R., Schwarcz, A., John, F., Varga, E., Bereczkei, T., Clemens, Z., Komoly, S., and Janszky, J., “Iron Concentration in Deep Gray Matter Structures is Associated with Worse Visual Memory Performance in Healthy Young Adults.”, J Alzheimers Dis, vol. 59, no. 2, pp. 675-681, 2017.
B. F. Darst, Huo, Z., Jonaitis, E. M., Koscik, R. L., Clark, L. R., Lu, Q., Kremen, W. S., Franz, C. E., Rana, B., Lyons, M. J., Hogan, K. J., Zhao, J., Johnson, S. C., and Engelman, C. D., “Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1041-1054, 2021.
B. F. Darst, Koscik, R. L., Racine, A. M., Oh, J. M., Krause, R. A., Carlsson, C. M., Zetterberg, H., Blennow, K., Christian, B. T., Bendlin, B. B., Okonkwo, O. C., Hogan, K. J., Hermann, B. P., Sager, M. A., Asthana, S., Johnson, S. C., and Engelman, C. D., “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
E. B. Dashinimaev, Artyuhov, A. S., Bolshakov, A. P., Vorotelyak, E. A., and Vasiliev, A. V., “Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.”, J Alzheimers Dis, vol. 56, no. 2, pp. 835-847, 2017.
R. David, Manera, V., Fabre, R., Pradier, C., Robert, P., and Tifratene, K., “Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1365-73, 2016.
E. J. Davidowitz, Krishnamurthy, P. K., Lopez, P., Jimenez, H., Adrien, L., Davies, P., and Moe, J. G., “In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.”, J Alzheimers Dis, vol. 73, no. 1, pp. 147-161, 2020.
S. Davidson, Allenback, G., Decourt, B., and Sabbagh, M. N., “Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1573-1584, 2023.
M. L. Daviglus, Bell, C. C., Berrettini, W., Bowen, P. E., E Connolly, S., Cox, N. Jean, Dunbar-Jacob, J. M., Granieri, E. C., Hunt, G., McGarry, K., Patel, D., Potosky, A. L., Sanders-Bush, E., Silberberg, D., and Trevisan, M., “National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline.”, Ann Intern Med, vol. 153, no. 3, pp. 176-81, 2010.
L. Dayon, Wojcik, J., Galindo, A. Núñez, Corthésy, J., Cominetti, O., Oikonomidi, A., Henry, H., Migliavacca, E., Bowman, G. L., and Popp, J., “Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1641-1652, 2017.
I. De Anda-Duran, Kolachalama, V. B., Carmichael, O. T., Hwang, P. H., Fernandez, C., Au, R., Bazzano, L. A., and Libon, D. J., “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., “Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
M. De Belder, Santens, P., Sieben, A., and Fias, W., “Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1171-1186, 2017.
A. de Calignon, Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T., “Propagation of tau pathology in a model of early Alzheimer's disease.”, Neuron, vol. 73, no. 4, pp. 685-97, 2012.
R. García de Eulate, Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., and Fernández-Seara, M. A., “Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.”, J Alzheimers Dis, vol. 58, no. 2, pp. 585-595, 2017.
R. A. A. de Heus, Reumers, S. F. I., van der Have, A., Tumelaire, M., Tully, P. J., and Claassen, J. A. H. R., “Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population.”, J Alzheimers Dis, vol. 74, no. 2, pp. 463-472, 2020.
C. A. de Jager, Msemburi, W., Pepper, K., and Combrinck, M. I., “Dementia Prevalence in a Rural Region of South Africa: A Cross-Sectional Community Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1087-1096, 2017.
S. M. de la Monte, Tong, M., and Wands, J. R., “The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1381-1390, 2018.
S. M. de la Monte, Tong, M., Daiello, L. A., and Ott, B. R., “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
S. M. de la Monte, “Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).”, J Alzheimers Dis, vol. 95, no. 4, pp. 1301-1337, 2023.
S. M. de la Monte, Tong, M., Schiano, I., and Didsbury, J., “Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 849-864, 2017.
J. C. de la Torre, “Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.”, J Alzheimers Dis, vol. 57, no. 2, pp. 353-371, 2017.
J. C. de la Torre, “Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1381-1396, 2021.

Pages